Skip to main content
. 2019 May 6;14(5):e0216062. doi: 10.1371/journal.pone.0216062

Table 1. Baseline characteristics of the study participants by incidence of anemia of chronic disease (ACD).

Characteristics Overall No incident ACD Incident ACD P value
Number 265,459 260,553 4,906 <0.001
Age (years)a 37.7 (8.0) 37.7 (8.0) 38.5 (9.0) <0.001
Male (%) 58.3 59.0 20.1 <0.001
Current smoker (%) 24.7 25.0 8.8 <0.001
Alcohol intake (%)c 17.4 17.6 8.0 <0.001
Vigorous exercise (%)d 14.7 14.7 13.7 0.046
High education level (%) 82.5 82.6 76.7 <0.001
Chronic kidney disease (%) 0.5 0.5 2.1 <0.001
Diabetes (%) 3.1 3.0 4.8 <0.001
Metabolic syndrome (%) 13.7 13.8 8.6 <0.001
Hypertension (%) 11.5 11.5 9.3 <0.001
Chronic liver disease 30.4 30.7 15.6 <0.001
COPD (%) 1.7 1.7 1.2 0.009
Obesity (%) 28.3 28.6 14.1 <0.001
BMI (kg/m2) 23.3 (3.2) 23.3 (3.2) 22.0 (2.9) <0.001
Systolic BP (mmHg)a 111.4 (13.5) 111.5 (13.5) 106.6 (14.4) <0.001
Diastolic BP (mmHg)a 71.9 (9.9) 72.0 (9.8) 68.1 (10.1) <0.001
Uric acid (mg/dl)a 5.4 (1.4) 5.4 (1.4) 4.6 (1.3) <0.001
eGFR 93.8 (15.4) 93.8 (15.4) 94.9 (17.6) <0.001
Hb (mg/dl)a 14.7 (1.4) 14.7 (1.4) 13.0 (0.9) <0.001
Glucose (mg/dl)a 94.3 (14.1) 94.3 (14.0) 94.0 (20.6) 0.164
Total cholesterol (mg/dl)a 191.7 (33.4) 191.8 (33.4) 185.6 (33.5) <0.001
LDL-C (mg/dl)a 113.5 (30.2) 113.6 (30.2) 104.8 (29.0) <0.001
HDL-C (mg/dl)a 56.3 (13.8) 56.2 (13.8) 60.3 (14.1) <0.001
Triglycerides (mg/dl)b 95 (67–142) 96 (67–142) 76 (57–109) <0.001
Ferritin (mg/dl)b 89.0 (40.7–165.7) 90.2 (41.1–167.2) 49.9 (29.8–84.4) <0.001
ALT (U/l)b 20 (14–29) 20 (14–29) 15 (12–21) <0.001
AST (U/l)b 21 (18–26) 21 (18–26) 20 (16–24) <0.001
GGT (U/l)b 20 (13–35) 20 (13–35) 13 (10–21) <0.001
HOMA-IRb 1.59 (1.05–2.22) 1.59 (1.05–2.22) 1.51 (0.94–2.06) <0.001
hsCRP (mg/l)b 0.4 (0.2–0.9) 0.4 (0.2–0.9) 0.3 (0.2–0.8) <0.001

Data are

ameans (standard deviation)

bmedians (interquartile range), or percentages.

Abbreviations: ALT, alanine aminotransferase; BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein-cholesterol; hsCRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment of insulin resistance.

c ≥ 20 g of ethanol per day

d ≥ 3 time per week